C6 Test as an Indicator of Therapy Outcome for Patients with Localized or Disseminated Lyme Borreliosis

Journal of Clinical Microbiology

Volumn 41, Issue 11, 2003, Pages 4955-4960

  Philipp, Mario T ^a   Marques, Adriana R ^b   Fawcett, Paul T ^d   Dally, Leonard G ^c   Martin, Dale S ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c EMMES CORPORATION   (United States)

^d NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIAL PROTEIN; C6 PEPTIDE; C6 PEPTIDE ANTIBODY; CEFUROXIME; PEPTIDE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BORRELIA BURGDORFERI; CHILD; CLINICAL FEATURE; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED STATES;

BACTERIA (MICROORGANISMS); BORRELIA; BORRELIA BURGDORFERI;

EID: 0242425788     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.11.4955-4960.2003     Document Type: Article

References (23)

1. Adderson, E. E. 2001. Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations. Springer Semin. Immunopathol. 23:387-403.
2. Bacon, R. M., B. J. Biggerstaff, M. E. Schriefer, R. D. Gilmore, M. T. Philipp, A. C. Steere, G. P. Wormser, A. R. Marques, and B. J. Johnson. 2003. Serodiagnosis of Lyme disease by kiinetic ELISAs using recombinat VlsE1 or peptide antigens of Borrelia burgdorferi compared with two-tiered testing using whole-cell lysates. J. Infect. Dis. 187:1187-1199.
3. Centers for Disease Control and Prevention. 1997. Case definitions for infectious conditions under public health surveillance. Lyme disease. Morb. Mortal. Wkly. Rep. 46:20-21.
4. Centers for Disease Control and Prevention. 1995. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morb. Mortal. Wkly. Rep. 44:590-591.
5. Centers for Disease Control and Prevention. 2002. Lyme disease-United States, 2000. Morb. Mortal. Wkly. Rep. 51:29-31.
6. Dressler, F., J. A. Whalen, B. N. Reinhardt, and A. C. Steere. 1993. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis. 167:392-400.
7. Engstrom, S. M., E. Shoop, and R. C. Johnson. 1995. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 33:419-427.
8. Fawcett, P. T., K. M. Gibney, C. D. Rose, S. B. Dubbs, and R. A. Doughty. 1992. Frequency and specificity of antibodies that crossreact with Borrelia burgdorferi antigens. J. Rheumatol. 19:582-587.
9. Fawcett, P. T., C. D. Rose, and K. M. Gibney. 1995. Comparative evaluation of adsorption with E. coli on ELISA tests for Lyme borreliosis. J. Rheumatol. 22:684-688.
10. Klempner, M. S., L. T. Hu, J. Evans, C. H. Schmid, G. M. Johnson, R. P. Trevino, D. Norton, L. Levy, D. Wall, J. McCall, M. Kosinski, and A. Weinstein. 2001. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N. Engl. J. Med. 345:85-92.
11. Larsen, S. A., B. M. Steiner, and A. H. Rudolph. 1995. Laboratory diagnosis and interpretation of tests for syphilis. Clin. Microbiol. Rev. 8:1-21.
12. Liang, F. T., E. Aberer, M. Cinco, L. Gern, C. M. Hu, Y. N. Lobet, M. Ruscio, P. E. Voet, Jr., V. E. Weynants, and M. T. Philipp. 2000. Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J. Infect. Dis. 182:1455-1462.
13. Liang, F. T., R. H. Jacobson, R. K. Straubinger, A. Grooters, and M. T. Philipp. 2000. Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 38:4160-4166.
14. Liang, F. T., A. C. Steere, A. R. Marques, B. J. Johnson, J. N. Miller, and M. T. Philipp. 1999. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J. Clin. Microbiol. 37:3990-3996.
15. Luft, B. J., R. J. Dattwyler, R. C. Johnson, S. W. Luger, E. M. Bosler, D. W. Rahn, E. J. Masters, E. Grunwaldt, and S. D. Gadgil. 1996. Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial. Ann. Intern. Med. 124:785-791.
16. McNemar, Q. 1947. Note on the sampling error of the difference between correlated proportions or percentages, Psychometrika 12:153-157.
17. Melski, J. W., K. D. Reed, P. D. Mitchell, and G. D. Barth. 1993. Primary and secondary erythema migrans in central Wisconsin. Arch. Dermatol. 129:709-716.
18. 6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J. Infect. Dis. 187:1178-1186.
19. 6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J. Infect. Dis. 184:870-878.
20. Steere, A. C. 2001. Lyme disease. N. Engl. J. Med. 345:115-125.
21. Steere, A. C., R. E. Levin, P. J. Molloy, R. A. Kalish, J. H. Abraham III, N. Y. Liu, and C. H. Schmid. 1994. Treatment of Lyme arthritis. Arthritis Rheum. 37:878-888.
22. Wormser, G. P., R. B. Nadelman, R. J. Dattwyler, D. T. Dennis, E. D. Shapiro, A. C. Steere, T. J. Rush, D. W. Rahn, P. K. Coyle, D. H. Persing, D. Fish, B. J. Luft, et al. 2000. Guidelines from the Infectious Diseases Society of America. Practice guidelines for the treatment of Lyme disease. Clin. Infect. Dis. 31(Suppl. 1):1-14.
23. Zhang, J. R., J. M. Hardham, A. G. Barbour, and S. J. Norris. 1997. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89:275-285.